PLPL Stock | News | Quote | Stock Forum | Thursday, December

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$PLPL Plandai Biotechnology, Inc. PLPL Company Overview 

Plandai Biotechnology, Inc. PLPL Current Price and Quotes
Last Price 0.40
Previous Close 0.411 Open 0.411
Daily Range 0.44 - 0.40 52wk Range 0.82 - 0.04
Volume 26,867 Dividend N/A
Average Vol (3m) 129,408 Yield N/A

PLPL Stock Message Board http://investorshangout.com/search?q=PLPL&...mp;yt1=Go!

Last Updated: Thursday, December 19, 2013 01:26:43 AM

Plandai Biotechnology, Inc. PLPL
Company Information

2226 Eastlake Avenue East
#156
Seattle, WA 98102
Australia

Website: http://www.plandaibiotech.com
Phone: 435-881-8734
Email: info@plandaibiotech.com

Plandai Biotechnology, Inc. PLPL
Planda Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market.
In November 2011, Planda Biotechnology, Inc. through its wholly-owned subsidiary acquired 100% ownership of Global Energy Solutions Corporation Limited (GES), through a share exchange.
Since 2002, GES successfully conducted documented research producing extracts from a variety of l...



Plandai Biotechnology, Inc. PLPL
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001317880
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2012
Employees 200 a/o Dec 01, 2012
Company Officers/Contacts

Roger Duffield CEO
Company Directors

Not Available
Company Notes

Formerly=Diamond Ranch Foods, Ltd. until 1-2012
Formerly=Jerry's, Inc. until 5-04. Jerry's, Inc. (FL) merged into Jerry's, Inc. (NV) prior to tha name change
Service Providers

Auditor/Accountant
Michael F. Cronin, CPA
1574 Eagle Nest Circle
Winter Springs, FL, 32708
United States

Legal Counsel
Mcgowan & Daniels
10004 Wurzbach Rd
San Antonio, TX, 78230
United States

Investor Relations Firm
Redwood Consultants, LLC
250 Bel Marin Keys Bldg.
Novato, CA, 94949
United States


Plandai Biotechnology, Inc. PLPL
PLPL Security Details

Share Structure

Market Value1 $43,697,832 a/o Dec 18, 2013
Shares Outstanding 106,320,760 a/o Nov 01, 2013
Float Not Available
Authorized Shares 500,000,000 a/o Dec 31, 2011
Par Value  0.0001
Shareholders

Shareholders of Record 299 a/o Sep 30, 2013
Security Notes

Capital Change=shs decreased by 1 for 50 split Pay date=05/13/2004.
Capital Change=shs decreased by 1 for 2000 split. Pay date=09/19/2008.
Short Selling Data

Short Interest 196,848 (1.19%)
Nov 29, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Signature Stock Transfer, Inc.

Plandai Biotechnology, Inc. PLPL Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Mar 31, 2011
Total Revenue 359 74 - 7,163
Cost of Revenue 963 - 113 5,273
Gross Profit (604) 74 (113) 1,890
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 1,919 3,884 23 2,352
Non-Recurring Items - - - -
Other 135 - - 23
Operating Income (2,658) (3,810) (136) (485)
Income From Continuing Operations

Add'l Income/Expense Items (45) - 53 22
Earnings Before Interest and Tax (2,703) (3,810) (83) (463)
Interest Expense 265 29 2 85
Earnings Before Tax (2,968) (3,838) (85) (548)
Income Tax - - - -
Minority Interest (780) (61) (15) -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,188) (3,777) (70) (548)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,188) (3,777) (70) (548)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,188) (3,777) (70) (548)

Plandai Biotechnology, Inc. PLPL Recent News

Dec 12, 2013 Plandai Biotechnology's CEO Discusses Direction of Medical Marijuana Subsidiary
Dec 11, 2013 Plandai Biotechnology, Inc. Announces Intellectual Property Filings
Dec 9, 2013 Plandai Biotechnology, Inc. to Focus Marijuana Research on Neuron Disorders Including Alzheimer's, Parkinson's, and Multiple Sclerosis
Nov 26, 2013 Plandai's Medical Marijuana Research Could Benefit From FDA Approval of Clinical Trials
Nov 20, 2013 Plandai to Provide New Formula in Diet Industry Profit Quest
Nov 19, 2013 New Report Shows Plandai Biotechnology's Diabetes Research More Important Than Ever
Nov 14, 2013 Plandai Biotechnology's Move Into Medical Marijuana Research Gets Validation With New Study
Nov 1, 2013 Plandai Enters Medical Marijuana Market
Oct 31, 2013 Plandai Biotechnology Enters Medical Marijuana Arena With Industry-Changing Technology
Oct 30, 2013 Plandai Biotechnology, Inc. to Enter Medical Marijuana Field With Phyto Cannabinoid Extract

1
2
next >

PLPL Plandai Biotechnology, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PLPL&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PLPL/quote
Stock Chart http://www.otcmarkets.com/stock/PLPL/chart
Company Info http://www.otcmarkets.com/stock/PLPL/company-info
Recent News http://www.otcmarkets.com/stock/PLPL/news
Financials http://www.otcmarkets.com/stock/PLPL/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PLPL/filings
Short Sales http://www.otcmarkets.com/stock/PLPL/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PLPL/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PLPL/research
Summary http://finance.yahoo.com/q?s=PLPL
Historical Prices http://finance.yahoo.com/q/hp?s=PLPL+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PLPL
Basic Chart http://finance.yahoo.com/q/bc?s=PLPL+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PLPL+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PLPL+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PLPL+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PLPL+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PLPL+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PLPL+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PLPL+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PLPL+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PLPL+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PLPL
Balance Sheet http://finance.yahoo.com/q/bs?s=PLPL
Cash Flow http://finance.yahoo.com/q/cf?s=PLPL+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PLPL
Market Watch http://www.marketwatch.com/investing/stock/PLPL
Bloomberg http://www.bloomberg.com/quote/PLPL:US
Morningstar http://quotes.morningstar.com/stock/s?t=PLPL
Bussinessweek http://investing.businessweek.com/research/st...icker=PLPL
Barchart http://www.barchart.com/quotes/stocks/PLPL
OTC Short Report http://otcshortreport.com/index.php?index=PLPL
Investopedia http://www.investopedia.com/markets/stocks/PLPL/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Occidental Bets Big on Argentine Sunflower Boom

Updated Category News Views 4

The Sunflower Seed Gamble When a company like Occidental Resources plunks down $200 million for sunflower seeds, you sit up and take notice. We're talking 300,000 metric tons of those little yellow gems sourced from Argentina, which according to the Rosario Board of Trade, is rolling in a whopping 6.6 million metric tons of sunflower product this year. Doesn't sound like...

Continue Reading
Cracking Down on Insider Trading: Legal vs Illegal

Updated Category News Views 8

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Continue Reading
Chicago Nurses Fight for Unionization Amid Tensions

Updated Category News Views 7

Nurses in Chicago Make a Stand for Union Representation When healthcare workers start flexing their collective power, it signals brewing trouble not just for management but the entire system. Those nurses over at Endeavor Health in Chicago are fed up, and, frankly, I can’t blame them. On October 23, they’re gathering to make a big move—you know, filing for a union...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 2

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
MISO Unveils Major Energy Grid Project in Iowa

Updated Category News Views 7

Ameren's Game Plan in Iowa There's always something cooking in the energy grids, and this time, MISO's picking up the phone to call a heavy-hitting consortium. Ameren Corp, which flies under the NYSE as AEE, teams up with GridLiance and Dairyland Power Cooperative to kickstart an ambitious grid venture in Iowa. Now, if you're a betting trader, you'd want to size up how...

Continue Reading
Ohas Unveils £1.5M Health Clinic in London

Updated Category News Views 3

Ohas Steps into the Healthcare Spotlight Ohas is setting its sights on the UK healthcare scene with a new clinic launching in London come January 2027. This isn’t about throwing another dull clinic into the mix. No, it’s about changing the narrative on how we handle health. Founded by health tech entrepreneur Richard Chambers and NHS GP Dr. Luke Pratsides, Ohas is...

Continue Reading
MiniTool ShadowMaker 5.0: New Cloud Sync Feature

Updated Category News Views 5

Pushing the Boundaries with Cloud Sync Another day, another software upgrade. MiniTool ShadowMaker has jumped to version 5.0, throwing in a new Cloud Sync feature for Google Drive and OneDrive. Now, you might not be jumping out of your chair with excitement just yet, but hear me out. For those who fiddle with Windows backup and file sync often enough to owe Microsoft a...

Continue Reading
CardVault by Tom Brady Expands to Pittsburgh

Updated Category News Views 2

Tom Brady’s CardVault Hits Pittsburgh’s Historic Strip District Pittsburgh just got another feather in its cap with CardVault by Tom Brady marking its 20th store at The Terminal. As if this city needed more sports excitement! Pittsburgh, with its die-hard Steelers, Penguins, and Pirates fans, snags a premium spot for sports collectibles. A Prime Spot for Serious...

Continue Reading
MSG Rangers Joining S&P SmallCap 600: Key Moves

Updated Category News Views 7

MSG Rangers Takes Center Ice—In the Market Here we go—MSG Rangers (NYSE: MSGR) is sliding into the S&P SmallCap 600 like a puck on fresh ice, ready to switch places with Arbor Realty Trust (NYSE: ABR) come October 27. Now, that's not just a game changer for MSGR, but also throws some shuffle onto the board for investors in these organizations. We've got Madison Square...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading

Top 5 Most Recently Viewed Articles

Minerals Technologies Reveals Q3 Call Details and Insights

Updated Category News Views 147

Minerals Technologies Inc. Schedules Third Quarter Conference Call NEW YORK, September 2025 - Minerals Technologies Inc. (NYSE: MTX), a premier technology-driven specialty minerals entity, is excited to announce the forthcoming release of its financial results for the third quarter of the year. These results will be disclosed after market close on a designated Thursday,...

Continue Reading
How a $100 Investment in BALL Stock Could Grow Over Time

Updated Category News Views 58

Understanding the Long-Term Growth of BALL Stock Over the last two decades, Ball Corporation (NYSE: BALL) has proven to be a solid investment choice, outperforming the broader market by an impressive margin. With an average annual return of 9.9%, investors have seen remarkable growth, illustrating the benefits of long-term investing. The Impact of Compounded Returns The...

Continue Reading
Rosedale Federal and CorServ Unveil Advanced Credit Card Solutions

Updated Category News Views 160

Rosedale Federal and CorServ Collaboration Rosedale Federal Savings & Loan Association has entered a significant partnership with CorServ, a pioneer in payment card solutions. This collaboration aims to transform the credit card experience for both its business and consumer clients, making banking more accessible and convenient. With an extensive history dating back to...

Continue Reading
Fotona Welcomes Daniel Larko as New VP & General Manager

Updated Category News Views 215

Fotona Appoints Daniel Larko as Vice President & General Manager Fotona, a renowned name in medical laser technologies for aesthetics, surgery, dermatology, gynecology, and dentistry, has announced the appointment of Daniel Larko as its new Vice President and General Manager for North America. This strategic move marks a significant step in advancing the company’s...

Continue Reading
Iridex Reports Encouraging Q1 2025 Financial Performance

Updated Category News Views 210

Iridex Unveils Early Financial Outcomes for Q1 2025 Iridex Corporation (Nasdaq: IRIX), recognized for its groundbreaking laser-based medical solutions, has reported intriguing preliminary results for the first quarter of 2025. The company specializes in advanced treatments for glaucoma and retinal diseases, making significant strides in the medical field. Overview of...

Continue Reading